Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results

References

• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.
   PubMed Web of Science ®Google Scholar
• Bruix J, Reig M, Sherman M. (2016). Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150:835–53.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang K, Lin SM, et al. (2016). Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia 33:237–46.
   Web of Science ®Google Scholar
• Katyal S, Oliver JH III, Peterson MS, et al. (2000). Extrahepatic metastases of hepatocellular carcinoma. Radiology 216:698–703.
   PubMed Web of Science ®Google Scholar
• Senthilnathan S, Memon K, Lewandowski RJ, et al. (2012). Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients. Hepatology 55:1432–42.
   PubMed Web of Science ®Google Scholar
• Uchino K, Tateishi R, Shiina S, et al. (2011). Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 117:4475–83.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. (2011). Management of hepatocellular carcinoma: an update. Hepatology 53:1020–2.
   PubMed Web of Science ®Google Scholar
• Nakano M, Tanaka M, Kuromatsu R, et al. (2015). Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study. Cancer Med 4:1836–43.
   PubMed Web of Science ®Google Scholar
• Sohn W, Paik YH, Cho JY, et al. (2015). Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: treatment outcome and prognostic factors. J Hepatol 62:1112–21.
   PubMed Web of Science ®Google Scholar
• Weichselbaum RR, Hellman S. (2011). Oligometastases revisited. Nat Rev Clin Oncol 8:378–82.
   PubMed Web of Science ®Google Scholar
• Hellman S, Weichselbaum RR. (1995). Oligometastases. J Clin Oncol 13:8–10.
   PubMed Web of Science ®Google Scholar
• White ML, Atwell TD, Kurup AN, et al. (2016). Recurrence and survival outcomes after percutaneous thermal ablation of oligometastatic melanoma. Mayo Clin Proc 91:288–96.
   PubMed Web of Science ®Google Scholar
• Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. (2007). Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25:4575–80.
   PubMed Web of Science ®Google Scholar
• Collen C, Christian N, Schallier D, et al. (2014). Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients. Ann Oncol 25:1954–9.
   PubMed Web of Science ®Google Scholar
• Liu M, Huang GL, Xu M, et al. (2017). Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacy. Int J Hyperthermia 1–11. [Epub ahead of print]. doi: 10.1080/02656736.2017.1278622.
   Web of Science ®Google Scholar
• Lam CM, Lo CM, Yuen WK, et al. (1998). Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 85:1198–200.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Kamiyama T, Nakanishi K, et al. (2006). Pulmonary resection for metastases from hepatocellular carcinoma: factors influencing prognosis. J Thorac Cardiovasc Surg 131:1248–54.
   PubMed Web of Science ®Google Scholar
• Li X, Wang J, Li W, et al. (2012). Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases. Int J Hyperthermia 28:721–8.
   PubMed Web of Science ®Google Scholar
• Pan T, Xie QK, Lv N, et al. (2017). Percutaneous CT-guided radiofrequency ablation for lymph node oligometastases from hepatocellular carcinoma: a propensity score-matching analysis. Radiology 282:259–70.
   PubMed Web of Science ®Google Scholar
• Jung SM, Jang JW, You CR, et al. (2012). Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases. J Gastroenterol Hepatol 27:684–9.
   PubMed Web of Science ®Google Scholar
• Simon R, Norton L. (2006). The norton-Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens. Nat Clin Pract Oncol 3:406–7.
   PubMedGoogle Scholar
• Sasaki K, Shindoh J, Margonis GA, et al. (2017). Effect of background liver cirrhosis on outcomes of hepatectomy for hepatocellular carcinoma. JAMA Surg 152:e165059.
   PubMed Web of Science ®Google Scholar
• Gao F, Gu Y, Huang J, et al. (2012). Radiofrequency ablation of retroperitoneal metastatic lymph nodes from hepatocellular carcinoma. Acad Radiol 19:1035–40.
   PubMed Web of Science ®Google Scholar
• Hiraki T, Gobara H, Takemoto M, et al. (2006). Percutaneous radiofrequency ablation combined with previous bronchial arterial chemoembolization and followed by radiation therapy for pulmonary metastasis from hepatocellular carcinoma. J Vasc Interv Radiol 17:1189–93.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. (2014). Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology 273:241–60.
   PubMed Web of Science ®Google Scholar
• Li X, Fan W, Zhang L, et al. (2011). CT-guided percutaneous microwave ablation of adrenal malignant carcinoma: preliminary results. Cancer 117:5182–8.
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Nakamura K, Matsuoka T, et al. (2005). Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. AJR Am J Roentgenol 185:1299–306.
   PubMed Web of Science ®Google Scholar
• Sacks D, McClenny TE, Cardella JF, Lewis CA. (2003). Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199–S202.
   PubMed Web of Science ®Google Scholar
• Gupta GP, Massague J. (2006). Cancer metastasis: building a framework. Cell 127:679–95.
   PubMed Web of Science ®Google Scholar
• Hiraki T, Yamakado K, Ikeda O, et al. (2011). Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan. J Vasc Interv Radiol 22:741–8.
   PubMed Web of Science ®Google Scholar
• Lee DY, Park JW, Kim TH, et al. (2015). Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma. Strahlenther Onkol 191:835–44.
   PubMed Web of Science ®Google Scholar
• Zeng ZC, Tang ZY, Fan J, et al. (2005). Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. Int J Radiat Oncol Biol Phys 63:1067–76.
   PubMed Web of Science ®Google Scholar
• Tiong L, Maddern GJ. (2011). Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 98:1210–24.
   PubMed Web of Science ®Google Scholar
• Timmerman RD, Bizekis CS, Pass HI, et al. (2009). Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 59:145–70.
   PubMed Web of Science ®Google Scholar
• Chen SW, Wang S, Wang B, et al. (2011). Metachronous pulmonary and adrenal metastases after liver transplantation for hepatocarcinoma. World J Surg Oncol 9:156.
   PubMed Web of Science ®Google Scholar
• Uppal A, Ferguson MK, Posner MC, et al. (2014). Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs. Clin Exp Metastasis 31:735–48.
   PubMed Web of Science ®Google Scholar
• Uppal A, Wightman SC, Mallon S, et al. (2015). 14q32-encoded microRNAs mediate an oligometastatic phenotype. Oncotarget 6:3540–52.
   PubMed Web of Science ®Google Scholar
• Shen L, Li W, Wang S, et al. (2016). Image-based multilevel subdivision of M1 category in TNM staging system for metastatic nasopharyngeal carcinoma. Radiology 280:805–14.
   PubMed Web of Science ®Google Scholar
• Eberhardt WE, Mitchell A, Crowley J, et al. (2015). The IASLC lung cancer staging project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 10:1515–22.
   PubMed Web of Science ®Google Scholar